Skip to main
  1. Stocks
  2. Diebold Nixdorf Inc
  3. Forecast
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is well positioned by its planned global collaboration with Euronet Worldwide, which should leverage both companies’ existing infrastructure, technology, and customer relationships to deliver integrated ATM outsourcing solutions that improve operating efficiency and expand revenue opportunities for financial institutions. The partnership thesis is supported by DBD’s core Banking franchise, a likely lift from higher memory prices that could increase system ASPs, revenues, and operating margins, and the expectation that current debt can be refinanced at more favorable rates when callable in December. Additional upside could come if the Brazilian ATM contract shifts into 2027, limiting near-term risk while reinforcing growth potential into 3Q26 and Q4'26.

Bears say

Diebold Nixdorf is facing a weak fundamental backdrop as tariff-related costs, supply-chain disruptions, and FX volatility threaten both revenue and margins, while management may not be able to fully offset these pressures in its forecasts. Demand trends are also unfavorable, with falling ATM demand, rising competition from alternative payment products and other vendors, and lower-than-expected upgrade and replacement activity in the Banking segment creating lumpier orders and slower project conversion. Liquidity and ownership concentration add further downside risk, as average daily volume is only about 150K shares, or roughly $7M, and top-4 debtholders reportedly control about 60% of common shares, amplifying volatility.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

DBD Analyst Forecast & Price Prediction

Get the latest DBD stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in DBD

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Oct 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


DBD Analyst Forecast & Price Prediction

Get the latest DBD stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in DBD

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover DBD stock data and trends